Empirical Versus Pre-emptive (Diagnostic-driven) Antifungal Therapy of Patients Treated for Haematological Malignancies or Receiving an Allogeneic Stem Cell Transplant. A Therapeutic Open Label Phase III Strategy Study of the EORTC Infectious Diseases and Leukemia Groups
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Caspofungin (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 29 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 24 Jul 2012 Additional trial location (Germany) added and official title amended as reported by German Clinical Trials Register record.